Predictive Genetic Counselling Market 2026-2034 | Size & Trends
Coverage: Predictive Genetic Counselling Market covers analysis By Setting Type (Direct-to-Consumer (DTC), Professional services); Predictive Testing (Genetic Susceptibility Test, Predictive Diagnostics, Population Screening); Application (Consumer Genomics, Breast and Ovarian Cancer, Cardiovascular Screening, Diabetic Screening and Monitoring, Colon Cancer); and Geography
- Report Date : Mar 2026
- Report Code : TIPRE00042208
- Category : Life Sciences
- Status : Upcoming
- Available Report Formats :
- No. of Pages : 150
The predictive genetic counselling market size is expected to reach USD 22.52 billion by 2034, up from USD 8.01 billion in 2025, growing at a robust CAGR of 12.17% during the forecast period 2026–2034.
Predictive Genetic Counselling Market AnalysisThe predictive genetic counselling market forecast indicates rapid growth with growing awareness of hereditary diseases and successful inclusions of genomics in personalized medicine, coupled with accelerating demand for early assessment of disease risks. Technological developments such as AI-powered genetic risk prediction, multi-omics platforms, and the upsurge of telehealth delivery models are some of the other factors that largely affect market growth. Additionally, increased penetration of employer-sponsored genetic health programs and at-home sample kit convenience continue to accelerate consumer adoption.
Predictive Genetic Counselling Market Overview
Predictive genetic counselling evaluates one's genetic vulnerability for diseases before symptoms have manifested. This service makes complex genomic data less daunting by putting genetic testing together with professional, expert counselling in order to facilitate critical healthcare decisions, lifestyle adjustments, and reproductive planning. Applications are wide, ranging from major fields such as oncology, cardiology, neurology, and the identification of rare diseases. It is increasingly a standard practice that is part of the routine clinical workflow, supported by streamlined digital health platforms and favorable reimbursement policies.
Strategic Insights
Predictive Genetic Counselling Market Drivers and OpportunitiesMarket Drivers:
- Increasing Prevalence of Genetic Disorders: Healthcare systems face a big challenge, with over 300 million people worldwide living with rare diseases, 70% of which come from genetic origins and manifest in childhood. This enormous patient burden brings about a necessity for early risk stratification and preventative counselling.
- Growing Demand for Personalized Medicine: The Global movement for treatment strategies will heavily rely on predictive counselling for betterment in clinical outcomes and therapeutic efficacy by matching treatments to the genetic makeup of an individual.
- Government and Employer Initiatives: Increased funding by the government for genomics research and the introduction of extensive employer-sponsored health programs are some of the major factors driving better awareness and access, which act as accelerants to market growth.
Market Opportunities:
- Emerging Market Expansion: The biggest growth is observed in emerging markets, especially the Asia-Pacific region, with its increasing healthcare investments, rapid digitization, and improvement in genomic literacy, offering huge untapped potential.
- Integration with Wearables and Digital Platforms: In blending the genetic insights with wearable health data and digital platforms, there opens up a unique opportunity to monitor risks in real time and strive for proactive health management.
- Multilingual and Remote Counselling Services: The development of telehealth and language-localized platforms is crucial for expanding global accessibility and overcoming geographical barriers to genetic counselling services.
The predictive genetic counselling market share is analyzed across various segments to provide a clearer understanding of its structure, growth potential, and emerging trends. Below is the standard segmentation approach used in most industry reports:
By Setting Type:
- Direct-to-Consumer (DTC): DTC services represent a perfect blend of accessibility and increasing demand from consumers in order to offer a way for individuals to get genetic insights, bypassing direct clinical mediators and making the initial assessment easier.
- Professional services: These services provide expert consultation and interpretation of complex genetic data according to the particular requirements of the clinical environment through established channels such as hospitals, clinics, and certified genetic counsellors.
By Predictive Testing:
- Genetic Susceptibility Test
- Predictive Diagnostics
- Population Screening
By Application:
- Consumer Genomics
- Breast and Ovarian Cancer
- Cardiovascular Screening
- Diabetic Screening and Monitoring
- Colon Cancer
By Geography:
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
The predictive genetic counselling market in the Asia Pacific is expected to witness the fastest growth during the forecast period, driven by rising disposable income, government backing in health technology initiatives, and rapidly expanding genomic literacy in the region.
Market Report Scope
Predictive Genetic Counselling Market Share Analysis by GeographyAsia Pacific is expected to grow fastest in the coming years. Emerging markets in South & Central America, the Middle East, and Africa also have many untapped opportunities for genetic counselling providers to expand. The predictive genetic counselling market shows a different growth trajectory in each region due to factors such as healthcare infrastructure, regulatory environment, and advanced technology adoption. Below is a summary of market share and trends by region:
North America:
- Market Share: Holds the largest market share due to its advanced healthcare infrastructure and early, high adoption rates of genetic testing.
- Key Drivers: Widespread employer-sponsored programs, substantial NIH funding, and deep integration of services within oncology and neurology networks.
- Trends: High rates of mutation identification and further expansion of predictive services.
Europe:
- Market Share: A significant share, driven by strong regulatory support and impactful national genomics initiatives.
- Key Drivers: Public funding for R&D, established BRCA screening programs, and national reimbursement policies.
- Trends: Increasing utilization of predictive diagnostics for hereditary cancer and neurodegenerative diseases.
Asia Pacific:
- Market Share: It is expected to be the fastest-growing region due to the rapid healthcare digitalization and expanding genomic literacy.
- Key Drivers: Increasing disposable income, government-driven healthcare technology initiatives, and recent launches of local direct-to-consumer platforms.
- Trends: Development of AI-based risk-scoring tools and modernization of access to healthcare.
South and Central America:
- Market Share: The market represents an emerging market that is increasingly developing an awareness of and need for advanced medical technology.
- Key Drivers: Expansion of private clinics, public health campaigns, and the need for affordable genetic screening.
Middle East and Africa:
- Market Share: Developing region with immense future potential; supported by growing governmental healthcare spending.
- Key Drivers: National health strategies aimed at infrastructure expansion and the rising demand for screening of hereditary diseases, especially in maternal and pediatric care.
High Market Density and Competition
The market is characterized by intense competition among established global leaders and innovative regional players offering diverse services. Competition pushes vendors to differentiate through:
- AI-powered risk prediction and sophisticated algorithms.
- Telehealth-enabled counselling and remote service delivery.
- Seamless integration with Electronic Health Records (EHR) and wearable platforms.
- Offering multilingual and culturally adaptive services to expand reach.
- F. Hoffmann-La Roche Ltd (Switzerland)
- Abbott Laboratories (U.S.)
- Thermo Fisher Scientific Inc. (U.S.)
- Agilent Technologies, Inc. (U.S.)
- Illumina, Inc. (U.S.)
- Myriad Genetics, Inc. (U.S.)
- QIAGEN (Germany)
- Pathway Genomics (U.S.)
- deCODE genetics (Iceland)
- Bio-Rad Laboratories, Inc. (U.S.)
Disclaimer: The companies listed above are not ranked in any particular order.
Predictive Genetic Counselling Market News and Recent Developments- F. Hoffmann-La Roche Ltd received FDA approval for Gazyva/Gazyvaro in lupus nephritis and reported strong 9-month sales growth. Roche announced that the FDA approved its drug Gazyva/Gazyvaro for the treatment of lupus nephritis, expanding its autoimmune portfolio. Roche also reported strong sales growth for the first nine months of 2025 and increased its full-year earnings outlook as strong performances in diagnostics and oncology boosted results.
- Abbott Laboratories launched a new CGM sensor facility in Ireland and invested $500M in U.S. diagnostics manufacturing. Abbott opened a manufacturing site in Kilkenny, Ireland, to meet global demand for FreeStyle Libre 3 continuous glucose monitoring sensors. The company also announced a $500 million investment in U.S. transfusion diagnostics, marking its entry into molecular nucleic acid testing.
The “Predictive Genetic Counselling Market Size and Forecast (2026–2034)” report provides a detailed analysis of the market covering the following areas:
- Market size and forecast at global, regional, and country levels for all key segments.
- Market trends, as well as market dynamics such as drivers, restraints, and key opportunities.
- Detailed PEST and SWOT analysis.
- Market analysis covering key trends, global and regional framework, major players, regulations, and recent developments.
- Industry landscape and competition analysis, including market concentration, heat map analysis, prominent players, and recent developments.
- Detailed company profiles.
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America holds the largest market share due to advanced infrastructure, while the Asia Pacific is the fastest-growing region, driven by rising income and healthcare digitization.
Major players include F. Hoffmann-La Roche, Abbott Laboratories, Thermo Fisher, Illumina, Myriad Genetics, and QIAGEN, among others.
The global market size is USD 8.01 billion in 2025, projected to reach USD 22.52 billion by 2034, exhibiting a robust CAGR of 12.17%.
The market is dominated by applications in oncology (e.g., breast, ovarian, colorectal cancers), cardiology, neurology, and the general consumer genomics segment.
Key drivers include the rising global prevalence of genetic disorders, the growing demand for personalized medicine, and rapid technological integration, especially AI-powered genetic risk prediction.
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely - analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You'll receive access to the report within 4-6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we'll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we're happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you're considering, and we'll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report's scope, methodology, customization options, or which license suits you best, we're here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we'll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we'll ensure the issue is resolved quickly so you can access your report without interruption.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For